🇺🇸 FDA
Pipeline program

administering RASI (the trade name or universal name will not be stipulated) before stenting

2023(728)

Phase 3 small_molecule active

Quick answer

administering RASI (the trade name or universal name will not be stipulated) before stenting for Carotid Stenosis is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Carotid Stenosis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials